PhotoCure presents positive results from a European multicentre study of Metvix® PDT in skin cancer unsuitable to conventional treatment
PhotoCure has recently reported positive results of Metvix® photodynamic therapy (PDT) in patients with actinic keratosis (pre-cancerous condition) and basal cell carcinoma (skin cancer).In this announcement we report a pivotal European multicentre study in patients with high-risk Basal Cell Carcinoma (BCC). A group of patients with BCC is considered as high-risk because they are not suitable for conventional treatment such as ordinary surgery, plastic surgery, or radiation therapy. In high risk BCC lesions, conventional treatment may cause unacceptable side effects such as